A phase I study of myo-inositol for lung cancer chemoprevention.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16896044
Conclusion of this study
myo-Inositol in a daily dose of 18 g p.o. for 3 months is safe and well tolerated. The potential chemopreventive effect as well as other health benefits such as reduction in blood pressure should be investigated further.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
